Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-interventional, Multicenter Clinical Study to Assess the Treatment With Atorvastatin in Patient Compliance With Hyperlipidemia and Other Cardiovascular Risk Factors

NCT02392416 is registered in ClinicalTrials.gov with Elpen Pharmaceutical Co. Inc. as lead sponsor.

NCT NCT02392416
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02392416 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-interventional, Multicenter Clinical Study to Assess the Treatment With Atorvastatin in Patient Compliance With Hyperlipidemia and Other Cardiovascular Risk Factors
Lead sponsor
Elpen Pharmaceutical Co. Inc.
Phase
Observational
Overall status
Completed
Start date
April 30, 2015
Completion date
February 29, 2016
Enrollment
900 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

dyslipidemia, hypercholesterolemia